Page last updated: 2024-11-01

octopamine and Benign Neoplasms

octopamine has been researched along with Benign Neoplasms in 1 studies

Octopamine: An alpha-adrenergic sympathomimetic amine, biosynthesized from tyramine in the CNS and platelets and also in invertebrate nervous systems. It is used to treat hypotension and as a cardiotonic. The natural D(-) form is more potent than the L(+) form in producing cardiovascular adrenergic responses. It is also a neurotransmitter in some invertebrates.
octopamine : A member of the class of phenylethanolamines that is phenol which is substituted at the para- position by a 2-amino-1-hydroxyethyl group. A biogenic phenylethanolamine which has been found to act as a neurotransmitter, neurohormone or neuromodulator in invertebrates.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dimić, DS1
Kaluđerović, GN1
Avdović, EH1
Milenković, DA1
Živanović, MN1
Potočňák, I1
Samoľová, E1
Dimitrijević, MS1
Saso, L1
Marković, ZS1
Dimitrić Marković, JM1

Other Studies

1 other study available for octopamine and Benign Neoplasms

ArticleYear
Synthesis, Crystallographic, Quantum Chemical, Antitumor, and Molecular Docking/Dynamic Studies of 4-Hydroxycoumarin-Neurotransmitter Derivatives.
    International journal of molecular sciences, 2022, Jan-17, Volume: 23, Issue:2

    Topics: 4-Hydroxycoumarins; Antineoplastic Agents; Carbonic Anhydrases; Cell Line, Tumor; Cell Proliferation

2022